Atherosclerosis-targeted liposome nanocarrier delivery system and preparation method therefor
US-2024424132-A1 · Dec 26, 2024 · US
Osteopontin production inhibitor containing dictyopyrone derivative or dihydrodictyopyrone derivative as active ingredient
US9463188B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9463188-B2 |
| Application number | US-201314766543-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 26, 2013 |
| Priority date | Mar 8, 2013 |
| Publication date | Oct 11, 2016 |
| Grant date | Oct 11, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed herein is an osteopontin production inhibitor capable of preventing a disease resulting from increased production of osteopontin. The osteopontin production inhibitor contains a dictyopyrone derivative or a dihydrodictyopyrone derivative as an active ingredient. The dictyopyrone derivative is preferably a compound represented by Chemical Formula 1 or 2, and the dihydrodictyopyrone derivative is preferably a compound represented by Chemical Formula 3 or 4.
First claim
Opening claim text (preview).
The invention claimed is: 1. An osteopontin production inhibitor comprising a compound dictyopyrone derivative represented by the following chemical formula 1 as an active ingredient: 2. An osteopontin production inhibitor comprising a compound dictyopyrone derivative represented by the following chemical formula 4 as an active ingredient: 3. An osteopontin production inhibitor comprising a compound dictyopyrone derivative represented by the following chemical formula 10 as an active ingredient: 4. An osteopontin production inhibitor comprising a compound dictyopyrone derivative represented by the following chemical formula 14 or 16 as an active ingredient: 5. The osteopontin production inhibitor of claim 4 , wherein the compound is represented by the chemical formula 14. 6. The osteopontin production inhibitor of claim 4 , wherein the compound is represented by the chemical formula 16.
Assignees
Inventors
Classifications
- A61K31/366Primary
having six-membered rings, e.g. delta-lactones · CPC title
- A61K31/45Primary
having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide · CPC title
having oxo groups directly attached to the heterocyclic ring · CPC title
specific for metastasis · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9463188B2 cover?
- Disclosed herein is an osteopontin production inhibitor capable of preventing a disease resulting from increased production of osteopontin. The osteopontin production inhibitor contains a dictyopyrone derivative or a dihydrodictyopyrone derivative as an active ingredient. The dictyopyrone derivative is preferably a compound represented by Chemical Formula 1 or 2, and the dihydrodictyopyrone der…
- Who is the assignee on this patent?
- Univ Tohoku, Nat Univ Corp Gunma Univ, Fuso Pharmaceutical Ind
- What technology area does this patent fall under?
- Primary CPC classification A61K31/366. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).